Hexabrix and Hemianopia homonymous - a phase IV clinical study of FDA data
Hemianopia homonymous is reported only by a few people who take Hexabrix.
The phase IV clinical study analyzes which people take Hexabrix and have Hemianopia homonymous. It is created by eHealthMe based on reports of 448 people who have side effects while taking Hexabrix from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
448 people reported to have side effects when taking Hexabrix.
Among them, 2 people (0.45%) have Hemianopia homonymous.
What is Hexabrix?
Hexabrix has active ingredients of ioxaglate meglumine; ioxaglate sodium. eHealthMe is studying from 448 Hexabrix users for its effectiveness, alternative drugs and more.
What is Hemianopia homonymous?
Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes) is found to be associated with 550 drugs and 261 conditions by eHealthMe.
Number of Hexabrix and Hemianopia homonymous reports submitted per year:
Time on Hexabrix when people have Hemianopia homonymous *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hemianopia homonymous when taking Hexabrix *:
- female: 0.0 %
- male: 100 %
Age of people who have Hemianopia homonymous when taking Hexabrix *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
* Approximation only. Some reports may have incomplete information.
Do you take Hexabrix and have Hemianopia homonymous?Check whether Hemianopia homonymous is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hemianopia homonymous and when was it recovered:
Expand to all the drugs that have ingredients of ioxaglate meglumine; ioxaglate sodium:
Alternative drugs to, pros and cons of Hexabrix:
- Hexabrix (448 reports)
Hemianopia homonymous treatments and more:
- Hemianopia homonymous (1,034 reports)
COVID vaccines that are related to Hemianopia homonymous:
- Hemianopia homonymous in Moderna COVID Vaccine
- Hemianopia homonymous in Pfizer BioNTech Covid Vaccine
- Hemianopia homonymous in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Hemianopia homonymous:
- Hemianopia homonymous (550 drugs)
All the conditions that are associated with Hemianopia homonymous:
- Hemianopia homonymous (261 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ioxaglate meglumine; ioxaglate sodium (the active ingredients of Hexabrix) and Hexabrix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Retroperitoneal Neoplasm and Thrombocytopenia - 2 seconds ago
- Chloramphenicol and Drowsiness - 5 seconds ago
- Cytoxan and Dermoid Cyst - 15 seconds ago
- Cogentin and Hepatitis C - 16 seconds ago
- Botox and Eosinophil Count Decreased - 23 seconds ago
- Magnesium and Common Peroneal Nerve Dysfunction - 27 seconds ago
- Myrbetriq and Hyperparathyroidism Secondary - 47 seconds ago
- Isovue-128 and Florinef drug interaction - a minute ago
- Heparin Sodium and Temporomandibular Joint Syndrome - a minute ago
- Acetaminophen vs. Bupropion Hydrochloride - a minute ago